(Q33615251)

English

Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

anti-retroviral agent

0 references

Clarisse Amani-Bosse

4

object named as

Clarisse Amani-Bosse

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

François Dabis

7

object named as

François Dabis

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Elaine J Abrams

6

object named as

Elaine J Abrams

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Didier K Ekouevi

8

object named as

Didier K Ekouevi

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Patrick Ahuatchi Coffie

1

object named as

Patrick A Coffie

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Besigin Tonwe-Gold

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Aristophane K Tanon

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Gédéon Bédikou

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

24 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

188

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2334-10-188

0 references

Implementing family-focused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Côte d'Ivoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

Sex differences in nevirapine rash

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904297

21 June 2018

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Hepatotoxicity associated with nevirapine use.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Appropriate use of nevirapine for long-term therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Nelfinavir and nevirapine side effects during pregnancy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Antiretroviral-associated toxicity among HIV-1-seropositive pregnant women in Mozambique receiving nevirapine-based regimens

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Nevirapine toxicity in a cohort of HIV-1-infected pregnant women

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Evaluation of a systematic substitution of zidovudine for stavudine-based HAART in a program setting in rural Cambodia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-10-188

21 January 2018

Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-10-188

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33615251&oldid=1899064528"